A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares.

Trial Profile

A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 20 Jul 2017

At a glance

  • Drugs Rilonacept (Primary) ; Allopurinol
  • Indications Gout
  • Focus Adverse reactions
  • Acronyms UPSURGE
  • Most Recent Events

    • 03 Oct 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 13 Jan 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 28 Oct 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top